The QuantiFERON Monitor® assay is predictive of infection post allogeneic hematopoietic cell transplantation.

Abby P DouglasLijia YuVijaya SundararajanJeff SzerDavid RitchieMonica A SlavinJoe SasadeuszKumar Visvanathan

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

This is a promising assay to demonstrate immune recovery and predict risk of infection after alloHCT and may allow tailoring of immunosuppression, antimicrobial treatment, and prophylaxis.

Keyphrases

high throughput
stem cell transplantation
bone marrow
combination therapy
replacement therapy